Figure 1 from Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
Year: 2025
Type: other
Abstract: Genomic alterations in BAA and White patients with pancreatic ductal adenocarcinoma. A, Percentage of patients with genomic changes in specific genes (row name). Q values represent adjusted P values after FDR correction. B, Distributions of KRAS mutant alleles in patients with pancreatic cancer. The “other” group includes wild-type KRAS and all other mutations that are not G12D, G12V, G12R, Q61H, or G12C. C and D, Association between KRAS mutants and KMT2C/D mutants, respectively. The number and colors represent percentages of patients with KMT2C or KMT2D mutations in specific KRAS mutant groups (Y) and the rest of patients (N). Column names represent the specific KRAS mutant alleles analyzed. The significance of differences between groups was calculated by Fisher’s exact test or χ2 test. Significance representation: N.S., P ≥ 0.05; **, 0.001 ≤ P < 0.01; ***, P < 0.001.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4406704468